ScienceDaily

Researchers have found a way to make ordinary aluminum tubes float indefinitely, even when submerged for long periods or punched full of holes. By engineering the metal’s surface to repel water, the tubes trap air inside and refuse to sink, even in rough conditions. The technology could eventually be scaled up into floating platforms, ships, or even wave-powered energy systems.

People who naturally stay up late may be putting their hearts under added strain as they age. A large study tracking more than 300,000 adults found that middle-aged and older night owls had poorer overall heart health and a higher risk of heart attack and stroke than those who were active earlier in the day, with the effect especially pronounced in women. Much of this elevated risk appeared to st…

Men start developing heart disease earlier than women, with risks rising faster beginning around age 35, according to long-term research. The difference is driven mainly by coronary heart disease, not stroke or heart failure. Traditional risk factors explain only part of the gap. The findings suggest earlier screening could help catch problems before serious damage occurs.

A new imaging technology called fast-RSOM lets researchers see the smallest blood vessels in the body without invasive procedures. It can detect early dysfunction in these vessels — a quiet warning sign of future heart disease — long before symptoms appear. Unlike traditional risk estimates, it measures real changes happening in the body. The portable system could one day be used in routine check…

On a remote Alaskan island, gray wolves are rewriting the rulebook by hunting sea otters — a behavior few scientists ever expected to see. Researchers are now uncovering how these coastal wolves adapted to marine hunting, what it means for land–sea ecosystems, and whether this ancient predator–prey relationship is re-emerging as sea otters recover.

A new drug developed by Australian researchers has shown promising results in reducing sepsis in a Phase II clinical trial involving 180 patients. The carbohydrate-based treatment works by calming a dangerous immune reaction that can cause organ failure. With no specific anti-sepsis therapy currently available, the findings mark a major step forward. Researchers now aim to move into Phase III tri…

Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a protein called periostin, the tumor remodels nearby tissue and invades nerves, which helps cancer cells travel and form metastases. This process also creates a tough, fibrous barrier that makes treatments less effective. Targeting periostin could help stop this invasion befor…

A fast-aging fish is giving scientists a rare, accelerated look at how kidneys grow old—and how a common drug may slow that process down. Researchers found that SGLT2 inhibitors, widely used to treat diabetes and heart disease, preserved kidney structure, blood vessels, and energy production as the fish aged, while also calming inflammation. The results help explain why these drugs protect kidney…

Two decades after a breast cancer vaccine trial, every participant is still alive—an astonishing result for metastatic disease. Scientists found their immune systems retained long-lasting memory cells primed to recognize cancer. By enhancing a key immune signal called CD27, researchers dramatically improved tumor elimination in lab studies. The findings suggest cancer vaccines may have been missi…

Order doesn’t always form perfectly—and those imperfections can be surprisingly powerful. In materials like liquid crystals, tiny “defects” emerge when symmetry breaks, shaping everything from cosmic structures to everyday technologies. Now, researchers have developed an AI-powered method that can predict how these defects will form and evolve in milliseconds instead of hours. By learning directl…

Scientists at Mount Sinai have unveiled a bold new way to fight metastatic cancer by turning the tumor’s own defenses against it. Instead of attacking cancer cells head-on, the experimental immunotherapy targets macrophages—immune cells that tumors hijack to shield themselves from attack. By eliminating or reprogramming these “bodyguards,” the treatment cracks open the tumor’s protective barrier …

Collagen pills sound like a shortcut to younger skin, but solid evidence doesn’t back them up. Higher-quality studies show little benefit, and your body doesn’t absorb collagen in the way ads suggest. Some supplements may even pose safety concerns and lack proper testing. Experts recommend focusing on proven habits like sunscreen, retinoids, and a nutrient-rich diet instead.

An experimental drug once known for helping control type 2 diabetes may also fight heart disease. Researchers found IC7Fc lowered cholesterol, blood fats, and artery-clogging plaques while calming inflammation linked to heart attacks and strokes. Notably, these benefits appeared even without weight loss, suggesting the drug could help lean people at risk of heart disease.

Scientists in Sweden and Norway have uncovered a promising way to spot Parkinson’s disease years—possibly decades—before its most damaging symptoms appear. By detecting subtle biological signals in the blood tied to how cells handle stress and repair DNA, the team identified a brief early window when Parkinson’s quietly leaves a measurable fingerprint.

Scientists studying ancient ocean fossils found that the Arabian Sea was better oxygenated 16 million years ago, even though the planet was warmer than today. Oxygen levels only plunged millions of years later, after the climate cooled, defying expectations. Powerful monsoons and ocean circulation appear to have delayed oxygen loss in this region compared to the Pacific. The discovery suggests fu…